Clinical Trials on Transient Ischemic Attacks in Australia

Total 422 results

AstraZeneca

Completed

THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death (THALES)

Acute Ischaemic Stroke | Transient Ischaemic Attack

Belgium, France, Italy, Spain, Sweden, Thailand, Germany, Korea, Republic of, Brazil, Hungary, India, Mexico, Vietnam, China, Taiwan, Hong Kong, Slovakia, Australia, Poland, Saudi Arabia, Ukraine, Canada, Russian Federation, Bulgaria, R... and more
AstraZeneca

Completed

[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES] (SOCRATES)

Acute Ischaemic Stroke | Transient Ischaemic Attack

Sweden, United States, Australia, Brazil, Bulgaria, France, Italy, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, Spain, Turkey, Vietnam, Germany, Philippines, China, Hungary, Romania, Ukraine, Hong Kong, Argentina, Bel... and more
VASCage GmbH
Medical University Innsbruck; St John of God Hospital, Vienna

Recruiting

Stroke-Card Registry

Ischemic Stroke | Transient Ischemic Attack

Austria
Assistance Publique - Hôpitaux de Paris
National Health and Medical Research Council, Australia; Bristol-Myers Squibb; Sano...

Completed

Aortic Arch Related Cerebral Hazard Trial (ARCH) (ARCH)

Embolism | Transient Ischemic Attack | Brain Infarction

Australia, France
Medtronic Cardiac Rhythm and Heart Failure
Medtronic Bakken Research Center

Completed

Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke (CRYSTAL-AF)

Cryptogenic Symptomatic Transient Ischemic Attack | Cryptogenic Ischemic Stroke

Netherlands, United States, France, Belgium, Germany, Sweden, Italy, Austria, Canada, Denmark, Finland, Greece, Slovakia, Spain
VITATOPS
National Health and Medical Research Council, Australia; National Heart Foundation... and other collaborators

Completed

VITATOPS: A Study of VITAmins TO Prevent Stroke

Stroke | Transient Ischemic Attack

Hong Kong, United Kingdom, Netherlands, Singapore, Australia, New Zealand, Italy, India, Malaysia, Portugal, United States, Sri Lanka, Philippines, Austria, Belgium, Brazil, Georgia, Moldova, Republic of, Pakistan, Serbia
Bayer

Recruiting

A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke (OCEANIC-STROKE)

Acute Non-cardioembolic Ischemic Stroke | Prevention of Ischemic Stroke | High-risk Transient Ischemic Attack

United States, Switzerland, Belgium, Sweden, Canada, Australia, Taiwan, Spain, Korea, Republic of, Latvia, Israel, Malaysia, Greece, Japan, Turkey, Netherlands, Romania, China, United Kingdom, Portugal, Italy, Brazil, France, Slovakia, ... and more
Bristol-Myers Squibb
Janssen, LP

Completed

A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel (AXIOMATIC-SSP)

Acute Ischemic Stroke | Transient Ischemic Attack (TIA)

France, Germany, Russian Federation, United States, China, Hong Kong, Korea, Republic of, Greece, Israel, Canada, Argentina, Australia, Austria, Belgium, Brazil, Chile, Czechia, Denmark, Finland, Hungary, Italy, Japan, Mexico, Norway, P... and more
Janssen Research & Development, LLC
Bristol Myers Squibb Company (BMS)

Recruiting

A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK)

Ischemic Stroke; Ischemic Attack, Transient

Italy, United States, Hong Kong, Japan, Taiwan, Korea, Republic of, Israel, United Kingdom, Argentina, Belgium, New Zealand, Canada, Germany, Denmark, Mexico, Croatia, France, Australia, Brazil, China, Czechia, Hungary, Netherlands, S... and more
Medical University Innsbruck
Barmherzige Brüder Vienna; Tiroler Landeskrankenanstalten GmbH (TILAK); Tiroler... and other collaborators

Completed

Post-Stroke Disease Management - Stroke Card (Stroke Card)

Stroke | Ischemic Attack, Transient | Cost-Benefit Analysis | Secondary Prevention | Disease Management

Austria
University of California, San Francisco
Medical University of South Carolina; The Emmes Company, LLC; Neurological Emergencies...

Terminated

Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial (POINT)

Ischemic Attack, Transient

Germany, New Zealand, United States, Canada, Spain, France, United Kingdom, Finland, Australia, Mexico
Karl Landsteiner University of Health Sciences
NÖ Landesgesundheitsagentur, legal entity of University Hospitals in Lower... and other collaborators

Recruiting

Echocardiographic Predictors of Atrial Fibrillation (EPAF-7)

Atrial Fibrillation | Stroke, Ischemic | Embolic Stroke of Undetermined Source | TIA, Brain

Austria
AstraZeneca

Completed

Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke

Ischemic Attack, Transient | Stroke, Acute | Cerebral Stroke | Cerebrovascular Stroke

United States, Australia, Brazil, Bulgaria, Czech Republic, France, Korea, Republic of, Mexico, Poland, Russian Federation, South Africa, Spain, United Kingdom, Philippines, China, Germany, Hungary, Hong Kong, Argentina, Austria, Cana... and more
University of Sydney
National Health and Medical Research Council, Australia

Active, not recruiting

PAEAN - Erythropoietin for Hypoxic Ischaemic Encephalopathy in Newborns (PAEAN)

Hypoxic-Ischemic Encephalopathy

Australia, Singapore, New Zealand
Clinuvel Pharmaceuticals Limited

Completed

A Proof of Concept Study to Evaluate the Safety of Afamelanotide in Patients With Acute Arterial Ischaemic Stroke (AIS)

Arterial Ischemic Stroke

Australia
University of Melbourne

Recruiting

Improving Early Reperfusion With Adjuvant Dornase Alfa in Large Vessel Ischemic Stroke (EXTEND-IA DNase)

Ischemic Stroke

Australia
DiaMedica Therapeutics Inc

Completed

Evaluation to Assess Safety and Tolerability of DM199 in Subjects With Acute Ischemic Stroke (ReMEDy1)

Acute Ischemic Stroke

Australia
University of Calgary
The George Institute for Global Health, Australia

Not yet recruiting

ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632 (ACT-WHEN)

Acute Ischemic Stroke AIS | Stroke, Acute, Stroke Ischemic | Stroke Acute

Canada, Australia
Vienna Hospital Association

Completed

Eccentric Manual Resistance Training in Patients With Ischemic CMP

Ischemic Cardiomyopathy

Austria
Grifols Therapeutics LLC

Completed

A Safety and Dose Finding Study of Plasmin (Human) Administered Into the Middle Cerebral Artery of Stroke Patients

Acute Ischemic Stroke

Spain, Australia, France, Austria, Serbia, Slovakia
Neuroscience Trials Australia
National Health and Medical Research Council, Australia; Monash University

Active, not recruiting

Trial of EXenatide in Acute Ischaemic Stroke (TEXAIS)

Acute Ischemic Stroke

Australia, Finland, New Zealand
Dart NeuroScience, LLC

Terminated

DNS-3379 vs. Placebo in Stroke Rehabilitation (SPIRIT)

Ischemic Stroke

Australia, New Zealand
The George Institute
National Health and Medical Research Council, Australia; Takeda; Conselho Nacional... and other collaborators

Completed

Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED) (ENCHANTED)

Ischemic Stroke | High Blood Pressure

Australia
Sanofi

Completed

PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)

Acute Ischemic Stroke

Korea, Republic of, Italy, Brazil, Canada, Colombia, Israel, Mexico, Poland, Czech Republic, United States, Australia, Austria, India, South Africa, Turkey
Medical University of Vienna

Completed

Retinal Neuro-vascular Coupling in Patients With Non-arteritic Anterior Ischemic Optic Neuropathy

Anterior Ischemic Optic Neuropathy

Austria
Craig Anderson
Johns Hopkins University; Genentech, Inc.; The George Institute for Global Health...

Recruiting

Optimal Post Tpa-Iv Monitoring in Ischemic Stroke

Acute Ischemic Stroke Patients Receiving Reperfusion Therapy

Australia, United Kingdom, United States, Chile, China, Malaysia, Mexico
University Hospitals Cleveland Medical Center
The University of Texas Health Science Center, Houston; Stryker Neurovascular

Completed

SELECT2: A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT2)

Acute Ischemic Stroke

Spain, United States, Canada, Australia, New Zealand, Switzerland
Neuroscience Trials Australia
The Florey Institute of Neuroscience and Mental Health

Completed

Tenecteplase Versus Alteplase Before Endovascular Therapy for Ischemic Stroke (EXTEND-IA TNK)

Ischemic Stroke

Australia, New Zealand
Stryker Neurovascular

Completed

Thrombectomy REvascularization of Large Vessel Occlusions in Acute Ischemic Stroke (TREVO) (TREVO)

Ischemic Stroke

Spain, Sweden, Germany, Austria
Medical University Innsbruck
VASCage GmbH; Tirol Kiniken GmbH; Barmherzige Brüder Vienna

Enrolling by invitation

Stroke Card Long-term Follow-Up

Ischemic Stroke | TIA

Austria
Neuroscience Trials Australia
The Florey Institute of Neuroscience and Mental Health

Completed

Determining the Optimal Dose of Tenecteplase Before Endovascular Therapy for Ischaemic Stroke (EXTEND-IA TNK Part 2)

Ischemic Stroke

Australia, New Zealand
Insel Gruppe AG, University Hospital Bern

Completed

Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (ELAN): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial (ELAN)

Ischaemic Stroke

Belgium, Ireland, Israel, Germany, India, United Kingdom, Austria, Switzerland, Finland, Norway, Italy, Portugal, Slovakia, Japan, Greece
Ever Neuro Pharma GmbH
IDV Data analysis and study planning Dr. Rahlfs

Recruiting

Cerebrolysin REGistry Study in Stroke - a High-quality Observational Study of Comparative Effectiveness (C-REGS2)

Acute Ischemic Stroke

Austria
Bod Australia
Woolcock Institute of Medical Research

Completed

The CANabidiol Use for RElief of Short Term Insomnia (CANREST)

Insomnia | Sleep Disturbance | Insomnia Type; Sleep Disorder | Insomnia, Transient | Insomnia Due to Anxiety and Fear | Insomnia Due to Other Mental Disorder

Australia
Medical University of Vienna

Completed

MYSTAR-5-YEAR: Long-term Follow-up of Patients With Ischemic Heart Disease Treated With Cell Therapy (MYSTAR-5-YEAR)

Acute Myocardial Infarction

Austria
Bilix Co.,Ltd.

Recruiting

A Study to Evaluate the Safety and Pharmacokinetics of BX-001N in Healthy Participants

Ischemia-reperfusion Injury

Australia
Nexel Co., Ltd.
Novotech (Australia) Pty Limited

Completed

A Study of NP-011 in Healthy Volunteers

Myocardial Infarction

Australia
Helios Health Institute GmbH
Heart Center Leipzig - University Hospital

Recruiting

Remote Ischemic Conditioning With Local Ischemic Postconditioning in High-Risk ST-elevation Myocardial Infarction (RIP-HIGH)

ST Elevation Myocardial Infarction

Austria, Germany
Daiichi Sankyo, Inc.

Completed

Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke (ASSENT)

Acute Ischemic Stroke | Thrombotic Disease

United States, Korea, Republic of, Taiwan, Australia, Spain, France, United Kingdom, Germany, Czechia, Italy, Slovakia
Medical University of Vienna
Odense University Hospital; Karolinska Institutet; The University of Texas Health... and other collaborators

Completed

Meta-Analysis of Cell-based CaRdiac stUdiEs: ACCRUE (ACCRUE)

Ischemic Heart Disease

Austria
Danube University Krems
NÖ Forschungs- und Bildungsges.m.b.H (NFB)

Completed

Austrian Polyintervention Study to Prevent Cognitive Decline After Ischemic Stroke (ASPIS)

Ischemic Stroke | Dementia | Cognitive Decline

Austria
Bayer
Population Health Research Institute

Completed

Study to Gather Information About Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following a Recent Non Cardioembolic Ischemic Stroke Which Occurs When a Blood Clot Has Formed Somewhere in the Human Body (But Not in the Heart) Travelled to the Brain. (PACIFIC-STROKE)

Acute Non-cardioembolic Ischemic Stroke

Spain, Japan, Australia, Czechia, Sweden, United Kingdom, Netherlands, Belgium, Russian Federation, Hungary, Slovakia, China, Germany, Switzerland, France, Poland, Denmark, United States, Austria, Bulgaria, Finland, Italy, Portugal
Shionogi

Recruiting

A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke (REvive)

Acute Ischemic Stroke

Japan, Israel, United States, Australia, Hong Kong
Sygnis Bioscience GmbH & Co KG

Completed

AXIS 2: AX200 for the Treatment of Ischemic Stroke (AXIS-2)

Acute Ischemic Stroke

Spain, Belgium, Germany, Slovakia, Austria, Czech Republic, Poland
Connecticut Children's Medical Center
Yale University; Columbia University; Gold Coast Hospital and Health Service; Newark... and other collaborators

Recruiting

Accuracy of Pediatric Emergency Medicine Providers in Diagnosing Hip Effusions Using Point of Care Ultrasound

Septic Arthritis | Hip Effusion | Transient Synovitis, Hip

United States, Australia
AbbVie

Active, not recruiting

A Safety and Efficacy Study of Intravenous (IV) Elezanumab Assessing Change in Neurologic Function in Adult Participants With Acute Ischemic Stroke

Acute Ischemic Stroke

United States, Australia, Canada, Japan, Korea, Republic of, Spain
R3 Vascular Inc.

Recruiting

Evaluation of the MAGNITUDE® Bioresorbable Drug-Eluting Scaffold in the Treatment of Patients With Below the Knee Disease in Australia (MAGNITUDE-BTK)

Critical Limb Ischemia | Critical Lower Limb Ischemia | Critical Limb-Threatening Ischemia

Australia
Quark Pharmaceuticals

Terminated

Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

Non Arteritic Anterior Ischemic Optic Neuropathy

United States, Australia, Germany, China, India, Italy, Singapore, Israel
Bayer

Completed

Repinotan in Patients With Acute Ischemic Stroke

Stroke | Acute Ischemic Stroke

Germany, Italy, Spain, United States, Canada, Finland, France, Australia, Netherlands, Belgium, Hungary, Israel, Sweden, Austria, United Kingdom
SurModics, Inc.

Completed

Safety and Feasibility of Surmodics SUNDANCE™ Drug Coated Balloon (SWING)

Peripheral Arterial Disease | Critical Lower Limb Ischemia

New Zealand, Australia, Austria, Germany, Latvia

Clinical Trials on Transient Ischemic Attacks in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations